Condition
Primary Peritoneal High Grade Serous Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Primary Peritoneal High Grade Serous Adenocarcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Japan (1), Puerto Rico (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Uterine Lavage to Screen BRCA Carriers for Ovarian Cancer Risk
This study tests whether rinsing the uterus with saline and analyzing the collected cells can help detect early signs of ovarian cancer in women with BRCA mutations who are planning risk-reduction surgery.
-
Testing Olaparib with or without Bevacizumab for Ovarian Cancer Treatment
This study is testing if a new cancer treatment called olaparib, alone or with another drug called bevacizumab, can help women with advanced ovarian cancer live longer without their cancer getting worse.
Related topics
Quick answers
How many Primary Peritoneal High Grade Serous Adenocarcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Japan (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.